This trial is !
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Cataract or Lens Opacity
and you are
over 50
years old
-
The phase for this study is not defined.
Show me locations

The purpose

This is a prospective, non-randomised, controlled, single-surgeon, single-center post-market clinical follow up study whereby patient undergoing routine cataract surgery will have bilateral implantation of a recently introduced TGA (Therapeutics Goods Authority, Australia) approved trifocal intraocular lens FineVision Evo (PhysIOL, Liège, Belgium). The primary and secondary effectiveness data for visual acuity, defocus curves, contrast sensitivity and any adverse events will be collected.

Provided treatments

  • Device: Implantation of IOL: PhysIOL POD F GF
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03027024. The sponsor of the trial is Physiol and it is looking for 20 volunteers for the current phase.
Official trial title:
Clinical Study to Investigate Visual Performance of Hydrophobic Trifocal IOL: FineVision HP